Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.020 (0.95%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $44.6 million as of September 8, 2026. Its market cap has increased by 0.67% in one year.
Market Cap
44.60M
Enterprise Value
30.84M
1-Year Change
0.67%
Ranking
Category
Stock Price
$2.12
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $44.60M, a decrease of -99.35%. That is a compound annual growth rate of -35.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 44.60M | -8.80% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 50.02M |
| Tevogen | 47.73M |
| Werewolf Therapeutics | 47.63M |
| aTyr Pharma | 47.16M |
| Celularity | 44.58M |
| Veru Inc. | 43.99M |
| Metagenomi Therapeutics | 43.82M |
| Mereo BioPharma Group | 40.66M |